DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering.
This report features an extensive study of the current market landscape and future potential of the protein design and engineering services and technology providers. The study features an in-depth analysis, highlighting the capabilities of protein design and engineering services and technology providers engaged in this domain.
Over the past few years, protein-based therapeutics, including peptides, hormones, vaccines, monoclonal antibodies, blood factors and therapeutic enzymes, have gained a lot of attention from clinical researchers engaged in the field of drug development. The success of these therapeutics can be attributed to the various clinical benefits offered by such products, such as high target specificity, low toxicity and favorable safety profiles. It is worth mentioning that, at present, the protein / peptide therapeutic pipeline features over 345 product candidates, which are being evaluated across more than 1,500 clinical trials worldwide. Further, over 55 such therapies have already been marketed to treat multiple therapeutic indications.
However, developing a protein based therapeutic is often fraught with several challenges, such as short half-life and poor chemical and physical stability. To overcome the aforementioned challenges as well as enable the development of therapeutic proteins with improved characteristics, researchers have identified various protein design and engineering techniques. Engineering a protein is a complex multistep process which requires high-throughput techniques and screening procedures. Additionally, it is a time and cost intensive process. Therefore, innovators in the pharmaceutical industry are constantly identifying / developing ways to improve the process of protein engineering.
Amidst other alternatives, outsourcing protein design and engineering process to a specialized service provider, having the required capability, has emerged as a viable option for various protein / peptide therapeutic developers. Presently, over 85 protein design / protein engineering service providers, along with technology providers, are actively supporting the development of novel protein / peptide therapeutics. The growing interest of pharmaceutical stakeholders in this field is also reflected from the recent rise in partnership activity related to protein design and engineering.
Additionally, over 550 patents related to protein design and engineering techniques have been filed / granted in the past few years, demonstrating the continued innovation being carried out in this domain. Driven by the growing demand for therapeutic proteins for personalized medicine and advancement in protein engineering tools, this market is anticipated to witness steady growth in the coming years.
Companies Mentioned
- 13therapeutics
- 9 Meters Biopharma
- Ablynx
- Absolute Antibody
- Abzena
- Accelero Biostructures
- Advanced Accelerator Applications
- AffyPro
- Aileron Therapeutics
- Akashi Therapeutics
- Allozymes
- Allysta Pharmaceuticals
- Altimmune
- Ambrx
- Amgen
- Aminoverse
- Amolyt Pharma
- Ampio Pharmaceuticals
- Amyndas Pharmaceuticals
- Anji Pharmaceuticals
- Apellis Pharmaceuticals
- Apeptico
- APIM Therapeutics
- Apitope
- Aquestive Therapeutics
- Arch Biopartners
- Arzeda
- AsclepiX Therapeutics
- Astellas Pharma
- AstraZeneca
- Atox Bio
- Atreca
- ATUM
- August Bioservices
- Aurinia Pharmaceuticals
- Averin Biotech
- Avilex Pharma
- Bayer
- Bicycle Therapeutics
- BioLineRx
- Biolingus
- Biologics International
- Biomarck Pharmaceuticals
- BioMarin Pharmaceutical
- BioMetis Technology
- BioTickle
- Among Many More Companies!
Key Questions Answered
- Who are the leading players engaged in providing protein design and engineering services?
- What is the relative competitiveness of different protein design and engineering service providers?
- What are the popular types of protein design and engineering technologies available in the market?
- What types of partnership models are commonly being adopted by stakeholders in this industry?
- How is the intellectual property landscape in this field likely to evolve in the foreseen future?
- Which are the most active clinical trial centers?
- What are the major market trends and driving factors that are likely to impact the growth of protein design and engineering market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. MARKET LANDSCAPE: PROTEIN DESIGN AND ENGINEERING SERVICE PROVIDERS
5. PROTEIN DESIGN AND ENGINEERING SERVICE PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS
6. COMPANY PROFILES: PROTEIN DESIGN AND ENGINEERING SERVICE PROVIDERS IN NORTH AMERICA
7. COMPANY PROFILES: PROTEIN DESIGN AND ENGINEERING SERVICE PROVIDERS IN EUROPE
8. COMPANY PROFILES: PROTEIN DESIGN AND ENGINEERING SERVICE PROVIDERS IN ASIA PACIFIC
9. MARKET LANDSCAPE: PROTEIN DESIGN AND ENGINEERING TECHNOLOGY PROVIDERS
10. PROTEIN DESIGN AND ENGINEERING TECHNOLOGIES: COMPETITIVENESS ANALYSIS
11. COMPANY PROFILES: PROTEIN DESIGN AND ENGINEERING TECHNOLOGY PROVIDERS
12. PARTNERSHIPS AND COLLABORATIONS
13. LIKELY PARTNERS ANALYSIS
14. PATENT ANALYSIS
15. CLINICAL TRIAL ANALYSIS
16. CASE STUDY: NOVEL PEPTIDE THERAPEUTICS
17. MARKET FORECAST AND OPPORTUNITY ANALYSIS
18. CONCLUDING REMARKS
19. EXECUTIVE INSIGHTS
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report visit https://www.researchandmarkets.com/r/m9nq9l
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900